© 2003 by Oxford University Press
Journal of the National Cancer Institute Monographs, No. 31, 14-19,
2003
© 2003 Oxford University Press
ARTICLE |
Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
Affiliations of authors: M. Schiffman, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD; S. K. Kjaer, Department of Viruses, Hormones and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
Correspondence to: Mark Schiffman, M.D., M.P.H., National Institutes of Health, 6120 Executive Blvd., Rm. 7066, Rockville, MD 20852 (e-mail: schiffmm{at}mail.nih.gov).
This chapter suggests promising areas of future epidemiologic research on human papillomavirus (HPV) and anogenital cancer, organized around our understanding of cervical carcinogenesis. The major steps in cervical carcinogenesis include HPV infection, HPV persistence over a certain period of time, progression to precancer, and invasion. Backward steps include clearance of HPV infection and regression of precancer. Additional studies of incident HPV infections among virgins initiating sexual activity could clarify the earliest aspects of transmission and immune response. Research on older women and their male partners should focus on understanding the determinants of varying age-specific HPV prevalence curves and underlying dynamics of viral persistence, clearance, and latency. It will be particularly important for epidemiologists to define HPV persistence rigorously in order to guide clinical management and vaccine trials. Intensive longitudinal studies that collect visual, microscopic (cytologic and histologic), and molecular data will be needed to understand the fate of individual HPV infections and to clarify whether multiple, concurrent infections act independently on the cervix. Case–control designs will be useful mainly in searching for new biomarkers of risk of progression among HPV-infected women that could then be validated prospectively. Prospective confirmation is also needed for the etiologic cofactors established by case–control studies of invasive cervical cancer. Much of the knowledge about cervical cancer might apply to anal neoplasia. Epidemiologic studies of other genital tumors such as penile neoplasia are still needed, but multicentric groups must place great emphasis on measurement technology, given the difficulty in obtaining reliable comprehensive measurements.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis Am. J. Epidemiol., July 15, 2008; 168(2): 123 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Buck, N. Cheng, C. D. Thompson, D. R. Lowy, A. C. Steven, J. T. Schiller, and B. L. Trus Arrangement of L2 within the Papillomavirus Capsid J. Virol., June 1, 2008; 82(11): 5190 - 5197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int. J. Epidemiol., June 1, 2008; 37(3): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lembo, M. Donalisio, M. Rusnati, A. Bugatti, M. Cornaglia, P. Cappello, M. Giovarelli, P. Oreste, and S. Landolfo Sulfated K5 Escherichia coli Polysaccharide Derivatives as Wide-Range Inhibitors of Genital Types of Human Papillomavirus Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1374 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Pereira, H R Lacerda, and R R Barros Prevalence and factors associated with anal lesions mediated by human papillomavirus in men with HIV/AIDS Int J STD AIDS, March 1, 2008; 19(3): 192 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Chan and J. S. Berek Impact of the Human Papilloma Vaccine on Cervical Cancer J. Clin. Oncol., July 10, 2007; 25(20): 2975 - 2982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Wood, Z. Chen, J. M. Cline, B. E. Miller, and R. D. Burk Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques J. Virol., June 15, 2007; 81(12): 6339 - 6345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Insinga, E. J. Dasbach, E. H. Elbasha, K.-L. Liaw, and E. Barr Incidence and Duration of Cervical Human Papillomavirus 6, 11, 16, and 18 Infections in Young Women: An Evaluation from Multiple Analytic Perspectives Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Albarran-Somoza, R. Franco-Topete, V. Delgado-Rizo, F. Cerda-Camacho, L. Acosta-Jimenez, M. Lopez-Botet, and A. Daneri-Navarro CEACAM1 in Cervical Cancer and Precursor Lesions: Association With Human Papillomavirus Infection J. Histochem. Cytochem., December 1, 2006; 54(12): 1393 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hampl, H. Sarajuuri, N. Wentzensen, H. G. Bender, and V. Kueppers Effect of Human Papillomavirus Vaccines on Vulvar, Vaginal, and Anal Intraepithelial Lesions and Vulvar Cancer Obstet. Gynecol., December 1, 2006; 108(6): 1361 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lipke An Armamentarium of Wart Treatments Clin. Med. Res., December 1, 2006; 4(4): 273 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Gunnell, T. N. Tran, A. Torrang, P. W. Dickman, P. Sparen, J. Palmgren, and N. Ylitalo Synergy between Cigarette Smoking and Human Papillomavirus Type 16 in Cervical Cancer In situ Development Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Sawaya A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance JAMA, November 2, 2005; 294(17): 2210 - 2218. [Full Text] [PDF]
|
|